Triamcinolona intravítrea en el tratamiento de la oclusión de rama venosa retiniana

  1. A Salinas-Alamán
  2. A García-Layana
  3. LM Sádaba-Echarri
  4. A Belzunce-Manterola
Revue:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Année de publication: 2005

Volumen: 80

Número: 8

Pages: 463-466

Type: Article

DOI: 10.4321/S0365-66912005000800007 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Archivos de la Sociedad Española de Oftalmologia

Objetivos de desarrollo sostenible

Résumé

Clinical cases: Five eyes with branch retinal vein occlusion (BRVO) were treated with intravitreal injection of 4 mg of triamcinolone. Four cases showed good visual acuity and macular thickness evolution after one dose. The remaining one case suffered a relapse three months later. Therefore a second injection was performed in that case. Discussion: Several treatments have been suggested to manage macular edema in BRVO. Intravitreal triamcinolone may be a therapeutic option to increase visual acuity and decrease macular thickness in patients with macular edema secondary to BRVO.

Références bibliographiques

  • Finkelstein, D. (1992). Ischemic macular edema: Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 110. 1427-1434
  • (1984). Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 98. 271-282
  • Firueroa, MS, Torres, R, Alvarez, MT. (2004). Comparative study fo vitrectomy with and without vein decompression for branch retinal vein occlusion: a pilot study. Eur J Ophthalmol. 14. 40-47
  • Karacorlu, M, Ozdemir, H, Karacorlu, S. (2004). Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients. Retina. 24. 324-327
  • Jonas, JB, Akkoyun, I, Kamppeter, B, Kreissig, I, Degenring, RF. (2004). Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye. 23. 1-7
La source de données: Dialnet